One-Visit HPV test and treatment could slash cervical cancer in poorer nations
NCT ID NCT05133661
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study is testing whether it's practical and acceptable to offer HPV testing and immediate treatment for precancerous cervical lesions in the same visit. It involves over 17,600 women in Burkina Faso, Côte d'Ivoire, Guatemala, and the Philippines. The goal is to see if this integrated approach can be rolled out widely to help eliminate cervical cancer in low- and middle-income countries.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
HPV testing and thermal ablation of precancerous lesions
What this could lead to
If successful, this approach could make cervical cancer screening and treatment more accessible in low-resource settings, moving the world closer to eliminating cervical cancer.
What could go wrong
This is an implementation study, not a test of a new drug or vaccine. It measures feasibility and acceptability, not long-term cancer prevention. Results may not apply to all regions or populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CERVICAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
CMA de Do
Ouagadougou, Burkina Faso
-
FSU Koko
Bouaké, Côte d’Ivoire
-
Metro-Manila
Quezon City, Philippines, 1103, Philippines
-
Quetzaltenango
Quetzaltenango, Guatemala